UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 13, 2017

 

 

 

MYOMO, INC.

(Exact name of registrant as specified in its charter)

 

 

  

Delaware   001-38109   47-0944526
(State or other jurisdiction   (Commission   (I.R.S. Employer
of incorporation)   File Number)   Identification No.)

 

 One Broadway, 14th Floor

Cambridge, Massachusetts 02142

(Address of principal executive offices, including zip code)

 

(617) 996-9058

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01Entry into a Material Definitive Agreement.

 

On November 13, 2017, Myomo, Inc. (the “Company”) and Sandcastle Limited Partnership (“Lender”) entered into an Amendment No. 3 to Amended and Restated Unsecured Term Promissory Note (the “Note Amendments”) for each of the Amended and Restated Unsecured Term Promissory Notes issued by the Company to Lender dated September 1, 2015, as amended (the “Notes”). Pursuant to the Note Amendments, the Company may elect, in its sole discretion, if its common stock is then-traded on the NYSE American or another stock exchange or over-the-counter dealer quotation system, to repay (i) up to 50% of the outstanding principal and any accrued but unpaid interest as shall be due and payable under the Notes by issuing shares of the Company’s common stock equal to 80% of the closing price per share of common stock on the repayment date, and (ii) the remainder of the outstanding principal and any accrued but unpaid interest as shall be due and payable under the Notes by issuing shares of the Company’s common stock equal to the closing price per share of common stock on the repayment date. However, in no event is the Company permitted to issue common stock for such repayment to the extent that such issuance would require shareholder approval under the rules of the NYSE American. In addition, the Company must make such election, if any, to repay the Notes in shares of its common stock no later than 90 days following the closing of the Company’s next offering of equity or equity-linked securities in which the Company receives gross proceeds of at least $2.0 million.

 

The foregoing description of the Note Amendments does not purport to be complete and is qualified in its entirety by reference to the text of the form of Note Amendments, which is included as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 1.02Termination of a Material Definitive Agreement.

 

On November 13, 2017 (the “Repayment Date”), the Company repaid Lender all outstanding principal and accrued but unpaid interest under the Notes, constituting approximately $1,081,928 in cash by issuing 107,505 shares of the Company’s common stock at a price per share equal to $5.03, 80% of the price per share of common stock on the Repayment Date and issuing 86,004 shares of the Company’s common stock at a price per share equal to $6.29, the price per share of common stock on the Repayment Date (the “Note Repayment”).

 

Item 3.02Unregistered Sales of Equity Securities.

 

The information contained in Item 1.01 and 1.02 with respect to the Amendments is incorporated by reference into this Item 3.02.

 

The shares of the Company’s common stock issued in connection with the Note Repayment were offered and sold in transactions exempt from the registration requirements of the Securities Act, in reliance on Section 4(a)(2) and Rule 506(b) of Regulation D. Lender represented that it was an “accredited investor” as defined in Regulation D.

  

Exhibit No.   Description
     
10.1   Form of Amendment No. 3 to Amended and Restated Unsecured Term Promissory Notes, dated November 13, 2017

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 14, 2017 Myomo, Inc.
   
  By: /s/ Paul R. Gudonis
    Paul R. Gudonis
   

Chairman, Chief Executive Officer and President (principal executive officer)

 

 

3

 

 

 

Exhibit 10.1

 

AMENDMENT NO. 3 TO AMENDED AND RESTATED UNSECURED TERM PROMISSORY NOTE

  

This AMENDMENT No. 3 entered into this ____ day of November, 2017 (this “Amendment”) to the Amended and Restated Unsecured Term Promissory Note effective September 1, 2015, issued by Myomo, Inc., a Delaware corporation (the “Maker”), to Sandcastle Limited Partnership (the “Lender”), as amended by Amendment No. 1 to Amended and Restated Unsecured Term Promissory Note on June 29, 2016 (“Amendment No. 1”) and Amendment No. 2 (“Amendment No. 2”) to Amended and Restated Unsecured Term Promissory Note on May 23, 2017.

 

WHEREAS, Maker issued to Steve Kelly on May 25, 2011 an Unsecured Term Convertible Promissory Note in the original stated principal amount of $[______] (as amended prior to the effectiveness of the Restated Note (as defined below), the “Original Note”);

 

WHEREAS, effective as of September 1, 2015, Maker and Lender amended and restated the Original Note in its entirety, in order to, among other things, reflect the transfer by Steve Kelly of all rights, title and interest to Lender under the Original Note (the “Restated Note”);

 

WHEREAS, on June 29, 2016, the Maker and Lender amended the Restated Note pursuant to Amendment No. 1 to, among other things, modify the repayment terms, provide for repayment in shares of the Maker’s capital stock in certain circumstances, and for subordination of the Restated Note to certain other indebtedness of the Maker, all as provided for in Amendment No. 1.

 

WHEREAS, on May 23, 2017, the Maker and Lender amended the Restated Note pursuant to Amendment No. 2 to, among other things, modify the repayment terms, all as provided for in Amendment No. 2.

 

WHEREAS, Maker and Lender now wish to further amend the Restated Note on the terms and conditions set forth herein, pursuant to Section 11 of the Restated Note, as amended to date.

 

WHEREAS, Maker represents that it has the power and authority to enter into this Amendment and no consent of any other third party is required for such entry by Maker.

 

NOW, THEREFORE, in consideration of the mutual covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

 

1.           Effective Date. This Amendment shall be effective as of the date first set forth above.

 

 

 

 

2.           Payments.

 

a.          Section 1 of the Restated Note is deleted in its entirety and the following is inserted in lieu thereof:

 

The outstanding balance shall bear interest at a rate of ten percent (10%) per annum, compounded annually based on a 365 day year, until such time as there is no amount outstanding hereunder. Subject to Section 2 hereof, all outstanding amounts then due under this Note shall be due and payable on June 8, 2019.

 

b.          Section 2 of the Restated Note is deleted in its entirety and the following is inserted in lieu thereof:

 

Notwithstanding anything to the contrary, but subject to the last sentence of this Section 2, Maker may elect, in its sole discretion, to repay up to fifty percent (50%) (rounded down to the nearest whole cent) of the aggregate outstanding amount (the principal amount and all accrued but unpaid interest thereon) under this Note (such amount, the “Discounted Stock Repayment Amount”) by issuing shares of Maker’s common stock, equal to the Discounted Stock Repayment Amount divided by that number equal to 80% of the closing price per share of Maker’s common stock quoted on the NYSE American (or another stock exchange or over-the-counter dealer quotation system on which Maker’s common stock is then traded) on the date of such repayment. In addition, notwithstanding anything to the contrary, but subject to the last sentence of this Section 2, Maker may elect, in its sole discretion, to repay the remainder of the aggregate outstanding amount (the principal amount and all accrued but unpaid interest thereon) under this Note that does not constitute the Discounted Stock Repayment Amount (the “Stock Repayment Amount”) by issuing shares of Maker’s common stock, equal to the Stock Repayment Amount divided by that number equal to the closing price per share of Maker’s common stock quoted on the NYSE American (or another stock exchange or over-the-counter dealer quotation system on which Maker’s common stock is then traded) on the date of such repayment. Notwithstanding the foregoing, (i) in no event shall Maker be required to, nor shall Maker, pursuant to this Section 2, issue shares of common stock or equity securities convertible or exercisable for shares of common stock to the extent that such issuance would require shareholder approval pursuant to Section 312.03 of the Listed Company Manual, (ii) Maker shall be permitted to make such election to repay the Discounted Stock Repayment Amount and/or the Stock Repayment Amount in shares of common stock as provided in this Section 2 no later than 90 days following the closing of Maker’s next offering of equity or equity-linked securities in which Maker receives gross proceeds of at least $2,000,000, pursuant to an effective registration statement under the Securities Act of 1933, as amended, or a private placement of such securities, in each case on or after November 8, 2017; and (iii) Maker shall be permitted to make such election to repay the Discounted Stock Repayment Amount and/or the Stock Repayment Amount in shares of common stock as provided in this Section 2 if and only if Maker’s common stock is then traded on the NYSE American (or another stock exchange or over-the-counter dealer quotation system) on the date of such repayment.

 

3.           In accordance with Section 3 of the Note, pursuant to which, among other things, the amounts outstanding under the Note and Maker’s obligations to the Lender are subordinated to certain other indebtedness of Maker, including that issued pursuant to the Accelerator Funding Agreement, dated July 7, 2011, between the Company and the Massachusetts Life Sciences Center, as amended (the “MLSC Loan”), Maker and the Lender agree, for the avoidance of doubt, that nothing contained in the Note shall require Maker to repay any amounts outstanding or due under the Note in cash so long as the MLSC Loan is outstanding or Maker is otherwise prohibited from doing so under the MLSC Loan, including pursuant to Section 4.2(f) thereof.

 

4.           Amendment Provision. This Amendment is entered into by Maker and Lender in a manner consistent with the provisions of Section 11 of the Restated Note. Except as expressly set forth in this Amendment, the Restated Note is not amended or modified, Lender has not waived the terms of any of the Restated Note, and the terms and conditions of the Restated Note are ratified and confirmed and such terms shall remain in full force and effect.

 

5.           General. Capitalized terms used herein and not defined shall have the meanings ascribed to them in the Restated Note. This Amendment may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. The terms of this Amendment shall be construed in accordance with the laws of the Commonwealth of Massachusetts, without regard to choice of law provisions.

 

 2 

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment on the date first written above.

 

LENDER:   MAKER:
SANDCASTLE LIMITED PARTNERSHIP              

MYOMO, INC.

         
By:     By:       
Name:                   Paul R. Gudonis
Title:       Chief Executive Officer

 

 

3